Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Comparison of DNA extraction methods for long-read mNGS testing

PROVIDER: PRJNA824617 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18712000_1.fastq.gz	Fastqsanger.gz
	SRR18712001_1.fastq.gz	Fastqsanger.gz
	SRR18712002_1.fastq.gz	Fastqsanger.gz
	SRR18712003_1.fastq.gz	Fastqsanger.gz
	SRR18712004_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 60

Similar Datasets

Project description:Comparison of soil DNA extraction for long read metagenomics

| PRJNA1090675 | ENA

Project description:DNA extraction comparison testing 2019-2020

| PRJEB40903 | ENA

human gut metagenome

Project description:Comparison of microbial DNA extraction methods for clinical applications

| PRJDB7617 | ENA

Project description:Comparison of extraction methods for recovering ancient microbial DNA from paleofeces

| PRJEB33577 | ENA

Project description:Comparison of DNA Extraction and Amplification methods for Plant-Associated Samples

| PRJNA646931 | ENA

Project description:Comparison of DNA extraction methods for human gut microbial community profiling

| PRJEB20983 | ENA

Project description:Comparison of Viral Nucleic Acid Extraction methods

| PRJNA470703 | ENA

Project description:DNA extraction kit comparison

| PRJNA925101 | ENA

Harnessing Bronchoalveolar Lavage Metagenomics for Distinguishing Lung Cancer from Pulmonary Infectious Diseases

Project description:Recent progress in unbiased metagenomic next-generation sequencing (mNGS) allows simultaneous examination of microbial and host genetic material in a single test. Leveraging affordable bronchoalveolar lavage fluid (BALF) mNGS data, we employed machine learning to create a diagnostic approach distinguishing lung cancer from pulmonary infections, conditions prone to misdiagnosis in clinical settings. This prospective study analyzed BALF-mNGS data from lung cancer and pulmonary infection patients, delineating differences in DNA/RNA microbial composition, bacteriophage abundances, and host responses, including gene expression, transposable element levels, immune cell composition, and tumor fraction derived from copy number variation (CNV). Integrating these metrics into a host/microbe metagenomics-driven machine learning model (Model VI) demonstrated robustness, achieving an AUC of 0.87 (95% CI = 0.857-0.883), sensitivity = 73.8%, and specificity = 84.5% in the training cohort, and an AUC of 0.831 (95% CI = 0.819-0.843), sensitivity = 67.1%, and specificity = 94.4% in the validation cohort for distinguishing lung cancer from pulmonary infections. The application of a rule-in and rule-out strategy-based composite predictive model significantly enhances accuracy (ACC) in distinguishing between lung cancer and tuberculosis (ACC=0.913), fungal infection (ACC=0.955), and bacterial infection (ACC=0.836). These findings highlight the potential of cost-effective mNGS-based analysis as a valuable tool for early differentiation between lung cancer and pulmonary infections, offering significant benefits through a single comprehensive testing.

2024-01-08 | GSE252118 | GEO

Project description:Benchmarking of long-read correction methods

| PRJNA610591 | ENA